Mengying Liu
P.R. China
Nanjing, 210008, China
Nanjing, 210008, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Comparative study on mouse models of acute exacerbation of pulmonary fibrosis.
Journal: Experimental and therapeutic medicine
Published: August 10, 2025
Population pharmacokinetics of imipenem and target attainment of pharmacokinetic/pharmacodynamic indices in Chinese adults with febrile neutropenia and hematological malignancies.
Journal: International journal of clinical pharmacy
Published: June 03, 2025
Successful Treatment of Mucormycosis and Azole-Resistant Aspergillus Coinfection in a Diabetic Patient: A Case Report.
Journal: Infection and drug resistance
Published: April 01, 2025
Pharmacovigilance analysis of polatuzumab plus bendamustine and rituximab treatment protocol: identifying comprehensive safety signals using FDA database.
Journal: Frontiers in pharmacology
Published: August 26, 2024
The potential lipid biomarker 5-HETE for acute exacerbation identified by metabolomics in patients with idiopathic pulmonary fibrosis.
Journal: Respirology (Carlton, Vic.)
Published: May 08, 2024
A disproportionality analysis for assessing the safety of FLT3 inhibitors using the FDA Adverse Event Reporting System (FAERS).
Journal: Therapeutic advances in drug safety
Published: August 10, 2023
The gene expression of CALD1, CDH2, and POSTN in fibroblast are related to idiopathic pulmonary fibrosis.
Journal: Frontiers in immunology
Published: August 09, 2023
Animal models of acute exacerbation of pulmonary fibrosis.
Journal: Respiratory research
Published: July 05, 2023
Optimal dosing regimen of biapenem based on population pharmacokinetic/pharmacodynamic modelling and Monte Carlo simulation in patients with febrile neutropenia and haematological malignancies.
Journal: International journal of antimicrobial agents
Published: November 10, 2022
Elevated Expression of Growth Differentiation Factor-15 Is Associated With Acute Exacerbation of Idiopathic Pulmonary Fibrosis.
Journal: Frontiers in immunology
Published: March 07, 2022
Danggui Buxue Decoction Ameliorates Idiopathic Pulmonary Fibrosis through MicroRNA and Messenger RNA Regulatory Network.
Journal: Evidence-based complementary and alternative medicine : eCAM
Published: January 13, 2022
Efficacy of Ceftazidime-Avibactam Versus Polymyxin B and Risk Factors Affecting Clinical Outcomes in Patients With Carbapenem-Resistant Klebsiella pneumoniae Infections a Retrospective Study.
Journal: Frontiers in pharmacology
Published: September 22, 2021
Last Updated: 09/26/2026